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ABSTRACT Light-dependent deactivation of rhodopsin as
well as homologous desensitization of .8-adrenergic receptors
involves receptor phosphorylation that is mediated by the
highly specific protein kinases rhodopsin kinase (RK) and
8-adrenergic receptor kinase (.iARK), respectively. We report
here the cloning ofa complementary DNA forRK. The deduced
amino acid sequence shows a high degree of homology to
jBARK. In a phylogenetic tree constructed by comparing the
catalytic domains ofseveral protein kinases, RK and flARK are
located on a branch close to, but separate from, the cyclic
nucleotide-dependent protein kinase and protein kinase C
subfamilies. From the common structural features we conclude
that both RK and PARK are members of a newly delineated
gene family of guanine nucleotide-binding protein (G protein)-
coupled receptor kinases that may function in diverse pathways
to regulate the function of such receptors.
Recent investigations have revealed previously unappreci-
ated and pervasive similarities between the components of a
wide variety oftransmembrane signaling systems. Many such
systems consist of specific receptors, functional coupling
proteins called guanine nucleotide-binding regulatory pro-
teins (G proteins), and effector enzymes or ion channels.
These elements form a chain that links an extracellular
stimulus to the perturbation of intracellular metabolic events.
Such systems mediate signals as diverse as those carried by
neurotransmitters, hormones, and sensory signals, such as
photons of light or odorants (1). Receptors in such systems
show a highly conserved structure featuring seven mem-
brane-spanning domains linked by hydrophilic extra- and
intracellular loops. Not only are the structural features of
such receptors highly conserved, it appears that, even in
disparate signaling systems, similar mechanisms may have
evolved to regulate the functioning of such receptor mole-
cules. Evidence from several systems suggests that phos-
phorylation ofthe receptor protein by highly specific receptor
kinases may represent an important and unifying mechanism
serving to dampen receptor function in the presence of
persistent or excessive stimulation (2, 3). Moreover, bio-
chemical data have suggested that an important property of
such receptor kinases is their ability to recognize and phos-
phorylate only the stimulus-modified or activated forms of
these receptors (4-7).
Previously, Lefkowitz and coworkers (8) cloned and se-
quenced cDNAs for the first member of this proposed
receptor kinase family, the f3-adrenergic receptor kinase
(j3ARK) (8). This kinase phosphorylates and regulates the
function of 8-adrenergic (and possibly other G-protein-
coupled) receptors by catalyzing phosphorylation of the
receptor on a serine/threonine-rich cluster found at its car-
boxyl terminus (9). Functionally, a very analogous enzyme is
rhodopsin kinase (RK). Discovered almost two decades ago
(4-6), this enzyme is known to phosphorylate rhodopsin,
thereby initiating its deactivation. The biochemical and func-
tional properties ofRK are such as to suggest that it might be
closely related toDARK (10). Accordingly we set out to clone
cDNAs for RK so as to elucidate its primary structure and
thereby clarify structural, evolutionary, and functional rela-
tionships with PARK, as well as to understand the nature and
diversity of the proposed family of receptor kinase mole-
cules.tt
MATERIALS AND METHODS
Protein Purification and Peptide Sequencing. RK was pu-
rified from bovine retina as described (11). The enzyme was
extracted from photobleached rod outer segment membranes
with 60 mM KC1. The kinase was further purified with a
DEAE-cellulose step, and pooled activity was then applied to
a hydroxyapatite column. RK was eluted in a buffer of20mM
1,3-bis[tris(hydroxymethyl)methylamino]propane, 1 mM
Mg(OAc)2, and 95 mM KC1. Fractions (1 ml) were concen-
trated to 300 A.l under reduced vacuum (Speed-Vac, Savant)
in individual Eppendorf tubes. To each of the 10 tubes was
added 700 p.l of CNBr in formic acid (99%) to give a final
CNBr concentration of 10 mM; the digestion was allowed to
proceed for 24 hr in the dark at room temperature. Each
sample was dried under reduced pressure and rehydrated
with 500 ,ul of 90%o water/10%o acetonitrile/0.1% trifluoro-
acetic acid. The 10 samples were individually applied to an
Aquapore C4 reverse-phase column (Applied Biosystems; 2.1
x 30 mm) at a flow rate of 200 p.l/min; the column was
washed with 1.5 ml of 0.1% trifluoroacetic acid in water
between each sample application. Once the last sample was
loaded, a gradient of 0-70% acetonitrile was developed.
Fractions were collected at 1-min intervals. A control digest,
consisting of 1 ml of buffer handled exactly as the kinase-
containing samples and subjected to CNBr treatment, was
chromatographed under identical conditions. Peaks unique to
the RK-containing digest were submitted for gas-phase pep-
tide sequencing (R. Randall, Howard Hughes Medical Insti-
tute Biopolymer Lab, Durham, NC).
cDNA Library Screening and Polymerase Chain Reaction
(PCR). Screening of a bovine Okayama-Berg cDNA library
(12) with the peptide-derived oligodeoxynucleotide 5'-
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CTGGGCAGTGTAGAAGATGGCICIGGGCTCCTG-
GAAGCCAGGGTTGTCCTCGTCCACGTTGTAGAT-
GTGGTAICIGATGTCACCACCGTTCAT-3' (where I is
deoxyinosine) yielded the partial clone N-9. A random-
primed bovine cDNA library in AZAPII (Stratagene) was
hybridized with a 520-base-pair (bp) Pst I fragment derived
from the 5' region of clone N-9 and clones S-1 and S-2 were
isolated. To obtain the amino-terminal sequences of RK the
RACE procedure (rapid amplification ofcDNA ends; ref. 13)
was used. Briefly, a first-strand cDNA was synthesized from
bovine retina poly(A)-selected RNA by using Superscript
reverse transcriptase (BRL) and the RK-specific primer
5'-TCTGGCAGGCGAACACCT-3' at 450C. The cDNA was
treated with RNase H, excess primer was removed by two
centrifugations through Centricon 100 filters (Amicon), and
the cDNA was tailed with poly(dA) by terminal deoxynucle-
otidyltransferase (BRL). Subsequent PCR amplification was
performed with Replinase (NEN/DuPont), 1 FLM RK-specific
primer 5'-CCAGTCCTCGCCCATGGGCTGG, 0.5 IAM
(dT)17-adapter primer 5'-GACTCGAGTCGACATCGA-
(T)17-3', and 1 luM adapter primer 5'-GACTCGAGTCGA-
CATCG-3'. Forty cycles of40 sec at 950C, 60 sec at 55TC, and
90 sec at 720C were performed. PCR products were size-
selected in an agarose gel and cloned in the plasmid vector
pCR1000 (Invitrogen, San Diego). All cDNA and PCR clones
were sequenced in both strands by the dideoxynucleotide
chain-termination method (14) and with 7-deaza-2'-deoxy-
guanosine 5'-triphosphate or 2'-deoxyinosine 5'-triphosphate
when necessary.
In Vitro Translation of the RK Construct. For in vitro
translation experiments, the construct pRK (Fig. 1) was
linearized with BamHI or HindIII and was then used for in
vitro transcription with either T7 (BamHI) or T3 (HindIII)
RNA polymerase (Stratagene). Capped RNA was translated
iii vitro with a rabbit reticulocyte lysate (BRL) in the presence
of 50 uCi (1.85 MBq) of [35S]methionine before samples were
run in an SDS/10%o polyacrylamide gel. After fixation in 40%o
methanol/10%o acetic acid for 30 min, the gel was dried and
subjected to autoradiography for 36 hr at room temperature.
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FIG. 1. Restriction map of the RK clones. The open reading
frame of 1683 bp is indicated by a heavy line. The polyadenylylation
signal at nucleotide 2879 is marked by a star. In clones N-9 and S-2
a poly(A) tail was found 15 bp downstream from the polyadenylyl-
ation signal. Clone N-9 was obtained by screening a bovine
Okayama-Berg cDNA library (12) with a peptide-derived oligonu-
cleotide. Clones S-1 and S-2 were isolated by hybridizing a random-
primed bovine cDNA library in AZAPII (Stratagene) with a 520-bp
Pst I fragment derived from the 5' region of clone N-9. Clones
including the amino-terminal sequence ofRK were obtained by the
RACE procedure (13). The clones R-12, R-13, R-4, and R-29 were
derived from four independent PCR reactions. Arrows indicate point
mutations in the nucleotide sequence of the respective PCR product.
For further experiments, the HindIII-Nco I fragment (bp 93-746)
from clone R-4, the Nco I-EcoRI fragment (bp 747-1705) from clone
S-1, and the EcoRI-BamHI fragment (bp 1706-2038) from clone N-9
were ligated into pT7T3 (Pharmacia), resulting in the construct pRK.
Although the HindIII-Nco I fragment ofclone R-4 contains two point
mutations, neither of these nucleotide exchanges leads to an amino
acid change in the translation product.
Expression of RK in COS-7 Cells. The HindIII-BamHI
fragment from the construct pRK was inserted into the
HindIII and BamHI sites of the expression vector pCMV5
(15). This fragment contains the complete coding block as
well as 112 bp of 5' untranslated sequence and 151 bp of 3'
untranslated sequence. COS-7 cells were grown to 60%6
confluence in Dulbecco's modified Eagle's medium contain-
ing 10%o fetal bovine serum and 50 mg of gentamicin per ml
and then were transfected with the vector pCMV5 or the
construct pCMV-RK by the DEAE-dextran method (16).
Forty-eight hours after transfection, cells from a 150-cm2 dish
were harvested in 0.4 ml of ice-cold buffer [10 mM Tris'HCl,
pH 7.5/10 mM Mg(OAc)2/5 mM dithiothreitol containing
each of the following protease inhibitors at 30 ug/ml: apro-
tinin, benzamidine, leupeptin, and pepstatin] and were lysed
with a Polytron homogenizer (Brinkmann) and centrifuged at
300,000 x g for 15 min. The supernatant was then analyzed
for RK activity, using urea-treated rod outer segments (17,
18). The RK assays contained 75 mM Tris HCI (pH 7.5), 1
mM dithiothreitol, 1 mM Mg(OAc)2, 100 ,uM (-32P]ATP
(2000 dpm/pmol), 30 ,uM rhodopsin, and either 3 Al of
pCMV5 supernatant or 3 ,1l of pCMV-RK supernatant. The
reaction mixtures were incubated in room light or in the dark
for 20 min at 25°C and terminated by addition of SDS sample
buffer followed by electrophoresis in an SDS/10% polyacryl-
amide gel. The gel was dried and subjected to autoradiogra-
phy for 15 min at room temperature.
Northern Blot Analysis. Following denaturation by glyox-
ylation, 5-,ug samples of poly(A)+ RNA from bovine tissues
were fractionated by electrophoresis in 1.2% agarose gels and
transferred to Biotrans membranes (ICN) as described (19).
The filters were hybridized with a nick-translated probe,
washed in 15 mM NaCl/1.5 mM sodium citrate, pH 7/0.1%
SDS, at 60°C, and subjected to autoradiography.
RESULTS AND DISCUSSION
RK was purified 1000-fold from bovine rod outer segments
(11) and 60 ,ug ofpurified RK was digested with CNBr in 99%6
formic acid. The peptides resulting from this cleavage were
resolved by reverse-phase HPLC. One of three peaks from
the HPLC yielded a distinct sequence of 30 amino acids when
subjected to gas-phase sequencing (NGGDIRYHIYNVD-
EDNPGFQEPRAIFYTAQ). An oligo(dT)-primed cDNA li-
brary from bovine retina in the Okayama-Berg vector (12)
was screened with an oligonucleotide probe (93 bp) derived
from this amino acid sequence and cDNA clone N-9 was
isolated (Fig. 1). Screening of a randomly primed cDNA
library from bovine retina in AZAPII (Stratagene) with the 5'
portion ofclone N-9 as a probe yielded two additional clones,
S-1 and S-2 (Fig. 1). We were unable to obtain clones coding
for the amino terminus of RK by screening of these and
several additional cDNA libraries (as well as genomic librar-
ies). Thus, we used the RACE strategy (13) to obtain se-
quences from the 5' end of the RK mRNA. Several clones
were obtained by amplifying specifically primed cDNA from
bovine retina poly(A)+ RNA.
Sequence analysis of four of the RACE clones revealed an
extremely G+C-rich 5' region with a G+C content of 71.2%
in the 680 most 5' bases (73.2% in 205 bp of 5' untranslated
region). We assume that this base composition accounted for
the difficulties in cloning the 5' portion of the RK mRNA.
Another feature of the nucleotide sequence of the clones we
obtained by the RACE procedure is the high number of point
mutations due to the relatively high infidelity of the DNA
polymerase under the conditions used (arrows in Fig. 1).
The nucleotide sequence from the clones analyzed gave a
total of 2898 bp (GenBank data base, accession no. M73836)
and contains an open reading frame of 1683 bp (561 amino
acids; Fig. 2) starting with a Kozak consensus sequence (22).
m
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RK MDrFGS ZT VfiJNSAFIAfNRGSFD SSGPASRDRKY[LARLKLPPLSKCEA[ i
BARK MADOJA LADVSYLM[IMZKSKXTPAARASKKILLLJPEPSIRSVMQ-KY[ 47
RK RZSLDLGp GMCLE~PIKRF QQ RTH:QHGALQLWKD---DYD96
BARK EDRGEVT[ KIK-FSQKL YLMRD[C[KHL ZAK LVzFYEZ KKYMEKLZ 96
TA DD AS-- -UP QK A QA L RA AYME P QA QL F CF L DA E T V A RAR A GA G D G[ETEEZE[VCSIC SE IFDTYIMKEL[ ACSHPFSKUSAIZHVQGHLVKKQVPPD[L!J
QPL L R A V L A LG Q A PQErL DOL[LYL LWMW EA Q-P X G E DWFiLD FV
[JY I E E I C Q NLIJRGD rQKrIzSDKtTjCJS LNIHLTMNDFSVH I
143
143
192
196
RK L[GRGZJFV QMKAFTL 242
BARK I|GRGG.G[ rGIRKAD|TG M<jNMMCM KX ISMQETL!LNERIMSL! 246
RK -- - I LArEKTDLCLVMTI| NGGDXI-IYVYNVDEDNPGPQ1P 289
BARK ST GDcpjriCMSYArH PDKSrILDL|NNGGD JL ----SQBGVrS[A 292
RK RAIJffTQMIVSzGLEELiQ NIXIYRDLKEPEMVE[V D-JDD[riVR1SD GL IVZL 339
BARK DMRYA Z 4IQ2GLZENIFVV|YRDLKA LHPB|VRISDLGL CDr 32
RK K EETKYDKsAGrPrF|ArirvPTL-MEESv F!VTnYYEMIAAR fP 388
BARK --SK K LKPHASVGHMYIMAP QKMGVAYDSSA WTS[ CMcFKKLLRGHS1!J 390
RK VARLVXNKMLKQR EQAITYRK|FSP|ASKrCLQDCX PZKXI1|RLQF 438
BARK PJQ'BKT -DKH IDRMT[ TM[ ELJLsQSPELRSL LLQRJVNRIL C 439
RK RDGSCDGLRTHPLFFDIS RQLEAGMLTPPFV PDSRT Y KNIQDVqF 487
BARK LGRGAQZVKESP rSLD QMVFLQKYPPPLIPJPRGE N ADAFDIS SD 489
RK - S T VFZV AFEKADTEFFQIFASGTCPIP;WQ ZIZTGVrGDL--VWifP 533
BARK EEDT[JIKLLDSDQZLYR FPL-TISERWJQEVAET-vrDTIRAJAETD[NL 536
RK DGQMPDDM[KGVSGQ[IAAPSSFiJSGMCVLS 561
BARK ZARKKTKNJQLGHZEDYAL GUIDCIMHGYMSNMGNPFLTQWQRRYFYQFPN 586
BARK RLEWRGEGEAPQSLLTMEEIQSVEETQIKERKCLLLKIRGGLQFVLQCDS 636
BARK DPELVQWKKELRDAYREAQQLVQRVPKMKNKPASPVVELSKVPLIQRGSA 686
BARK N GL 689
This open reading frame codes for a protein of 62.9 kDa,
which is in agreement with the molecular weight of purified
RK as reported by Kelleher and Johnson (23). An exact
amino acid match was found with the peptide sequence
determined by gas-phase sequencing in the middle of the
open reading frame (Fig. 2, residues 268-297). Initiation of
translation at the first ATG in the sequence was shown by in
vitro translation. The coding region of the RK cDNA was
cloned into pT7T3 (pRK, Fig. 1). Capped RNA was synthe-
sized and in vitro translated in a rabbit reticulocyte lysate
(BRL), giving rise to a major protein of 63 kDa (data not
shown).
The deduced amino acid sequence of RK was compared
with the sequences of several serine/threonine protein ki-
nases. Similarities to other protein kinases were mostly found
within the putative catalytic domain of RK, whereas the
degree of homology was lower when the amino and carboxyl
termini of RK were compared with those of other protein
kinases. RK is most closely related to PARK, showing 33.6%
amino acid identity overall and 44.2% identity in the catalytic
domains (boxed area in Fig. 2). The degree of amino acid
identity ofRK with the amino terminus of fBARK is 22.7% in
an overlap of 180 amino acids and 27.0%o with the carboxyl
terminus in an overlap of 102 amino acids. Comparisons of
the amino and carboxyl termini of RK with members of the
cyclic nucleotide-dependent protein kinase or protein kinase
C subfamilies revealed no significant similarities.
To further explore the sequence relationship ofRK to other
protein kinases, a phylogenetic tree was constructed by
comparing the catalytic domain with those of several other
protein kinases (Fig. 3). RK and the P3ARK isozymes
8ARK-1 and BARK-2 form a separate branch that is most
closely related to the cyclic nucleotide-dependent protein
FIG. 2. Alignment of the de-
duced RK amino acid sequence
with the BARK (BARK) se-
quence. Identical amino acids are
shown by bold letters in boxes;
bold letters indicate substitutions
by amino acids with close evolu-
tionary relationship as defined by
Dayhoff and normalized by Grib-
skov and Burgess (20). The large
box encompasses the catalytic do-
main. The star denotes the substi-
tution of leucine for phenylalanine
in the Asp-Phe-Gly consensus
(21). The myristoylation consen-
sus is shown in italics and the
CAAX box (where C is cysteine,
A is an aliphatic amino acid, andX
is the carboxyl-terminal amino
acid) is underlined in the RK
sequence.
kinase and protein kinase C subfamilies. These results sug-
gest thatRK andPARK are members ofa distinct gene family
of G-protein-coupled receptor kinases.
Both RK and PARK are acidotrophic serine/threonine
protein kinases phosphorylating serine/threonine clusters on
the carboxyl-terminal tail of rhodopsin and the /3-adrenergic
receptor, respectively (29, 30). The primary amino acid
sequence of RK places the catalytic domain of 270 amino
acids approximately in the center of the sequence flanked by
a 185-residue amino-terminal domain and a 106-residue car-
boxyl-terminal domain (Fig. 2). In terms ofdomain structure,
PARK differs from RK only by having a longer carboxyl-
terminal domain (125 amino acids). The similarities between
the amino-terminal domains of RK and PARK in length and
amino acid sequence suggest that this region of the kinases
has a common functional role, perhaps bestowing upon these
enzymes their ability to recognize and phosphorylate only the
activated forms of their respective receptors.
The catalytic domain of RK contains the essential land-
marks of a serine/threonine protein kinase: the motif Gly-
Xaa-Gly-Xaa-Xaa-Gly involved in ATP binding at position
193 (31), the conserved catalytic residues Asp-332 and Lys-
216 implicated in phosphoryl transfer (32-34), and the other
conserved features of protein kinase catalytic domains de-
scribed by Hanks et al. (21). A significant difference noted
earlier (8), however, between PARK and the other protein
kinases was the substitution in PARK of a leucine for
phenylalanine in the otherwise highly conserved Asp-Phe-
Gly consensus sequence implicated in ATP binding and
catalysis. This same replacement is also found in RK (Fig. 2)
and may possibly reflect a point of common evolutionary
divergence of these receptor kinases. This mutational change
may provide a marker, in addition to amino-terminal resem-
RK
BARK
RK
BARK
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FIG. 3. Phylogeny of the receptor kinase catalytic domains. The
catalytic domain of RK (amino acids 185-455) was compared with
the catalytic domains of several other protein kinases (21) by
construction of a dendrogram. The methodology used has been
described (24). The enzymes used for the comparison were ,ARK-1
and IARK-2 (25); cAMP-dependent protein kinase (cAPK); cGMP-
dependent protein kinase (cGPK); protein kinase C, a form (PKC-a);
yeast (Saccharomyces cerevisiae) protein kinase (YPK1, ref. 26); rat
S6 kinase (S6K, ref. 27); dicot bean (Phaseolus vulgaris L.) protein
kinase (PVPK, ref. 28); Ca2+/calmodulin-dependent protein kinase
type II, a subunit (CaM II-a); myosin light-chain kinase (MLCK-K);
"cell-division-cycle" gene product in yeast (cdc2+); Drosophila
casein kinase II, a subunit (DCK II); c-src protooncogene (c-src);
epidermal growth factor receptor (EGFR); and c-mos protooncogene
(c-mos).
blances, for protein kinases of the G-protein-coupled recep-
tor kinase class.
The primary structure of RK suggests that several inter-
esting posttranslational modifications may take place on the
enzyme. (i) Two amino acids beyond the proposed initiator
methionine (Fig. 2) lies the consensus sequence for myris-
toylation (35). Our inability to obtain protein sequence start-
ing from the amino terminus of purified bovine retinal RK
suggests that some type of modification resides at the amino
terminus of the protein. (ii) Eight potential phosphorylation
sites for acidotrophic protein kinases preferring serines and
threonines to the amino-terminal side of the acidic group
[e.g., RK (29, 30) and casein kinase 11 (36)] as well as four
potential protein kinase C-sensitive serines and threonines
(37) are present in RK. Some of the acidotrophic sites are
most likely sites of autophosphorylation known to occur on
RK (23, 38). (iii) The carboxyl terminus ends with a CAAX
box (Cys-Val-Leu-Ser) where C is a cysteine, A is an
aliphatic amino acid, and X is the terminal amino acid of the
protein. This sequence has been shown to direct isoprenyl-
ation of the cysteine, which appears to be the first of three
processing events that occur in proteins containing this
sequence. Following isoprenylation, proteolytic cleavage of
the carboxyl-terminal three amino acids (-AAX) and car-
boxymethylation of the isoprenylated cysteine has been
shown to occur in several proteins with the CAAX motif (for
review, see ref. 39 and references therein). Interestingly, the
primary amino acid sequences as deduced from the cDNA of
several retinal proteins involved in the visual signal trans-
duction pathway have been shown to carry the CAAX box,
including the 'y subunit of transducin (40, 41) and the a
subunit of the photoreceptor cGMP phosphodiesterase (42).
An expression plasmid for RK was constructed by insert-
ing the HindIII-BamHI fragment of pRK into the vector
pCMV5 (15). The resulting construct, pCMV-RK, was trans-
fected into COS-7 cells by the DEAE-dextran procedure (16).
l 2 3
Rho2-'-
Rho-- *
FIG. 4. Expression of RK in COS-7 cells. COS-7 cells were
transfected with the expression construct pCMV-RK or the vector
pCMV5 as described. Cytosol was analyzed for RK activity by using
30 A&M rhodopsin with either 3 .II of pCMV5 supernatant (lane 1) or
3 ,ul ofpCMV-RK supernatant (lanes 2 and 3). The reaction mixtures
were incubated in room light (lanes 1 and 2) or in the dark (lane 3) for
20 min at 25TC, and the reactions were terminated by addition ofSDS
sample buffer followed by electrophoresis in an SDS/10%0 homoge-
neous polyacrylamide gel. The gel was dried and subjected to
autoradiography for 15 min at room temperature. Rho, rhodopsin;
Rho2, rhodopsin dimer.
After 48 hr, cytosol preparations from cells transfected with
either pCMV5 or pCMV-RK were tested for RK activity.
Cells transfected with pCMV5 showed no RK activity (Fig.
4, lane 1). Cytosol preparations from cells transfected with
pCMV-RK phosphorylated rhodopsin in a light-dependent
manner (lanes 2 and 3).
To examine the size and localization of RK mRNA we
hybridized Northern blots of poly(A)+ RNA from various
bovine tissues with a radiolabeled 860-bp Pst I fragment from
clone S-1. In RNA from retina only, an mRNA species of 3.1
kilobases (kb) and to a lesser extent a species of 5.8 kb
hybridized to the probe used (Fig. 5). After longer exposures,
the same hybridization pattern was observed in RNA from
the pineal gland. The two major mRNA species detected in
the retina and pineal gland may be due to alternative proc-
essing of the same transcript, but the exact nature of these
mRNAs remains to be elucidated. The minor band of 5.0 kb
appears to result from cross-hybridization with a different
mRNA species. After longer exposures it was also detected
in RNA preparations from lung, spleen, pineal, and heart
(data not shown). The detection of RK mRNA in the pineal
SF _ ;zJ-o.X -
9
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FIG. 5. Northern blot analysis of RK mRNA in bovine tissues.
After hybridization with a nick-translated 860-bp Pst I fragment
containing the 5' portion of clone S-1, the blot was washed in 15 mM
NaCI/1.5 mM sodium citrate, pH 7/0.1% SDS at 60'C and subjected
to autoradiography for 4 hr at room temperature. The quality of the
RNA preparations was verified by rehybridization of this blot with
a,3ARK probe (data not shown). cer., Cerebral.
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gland is consistent With other biochemical similarities be-
tween the mammalian pineal gland and the retina (43, 44). The
highly specific expression of the RK gene in restricted tissues
underscores the specific function of this kinase in the phos-
phorylation of photoactivated rhodopsin. It remains to be
determined whether RK is also expressed in the cone cells
and whether it phosphorylates other (color) opsins in vivo.
Stimulus-dependent receptor phosphorylation occurring in
association with attenuation of receptor signaling has been
documented for diverse G-proteini-coupled receptors. These
include, in addition to the ,82-adrenergic receptor and
rhodopsin, the M2 muscarinic cholinergic receptor, the
cAMP receptor of Dictyostelium discoideum, and the pher-
omone a-mating-factor receptor of Saccharomyces cerevi-
siae (45-48). Moreover, numerous members of the family of
G-protein-coupled receptors contain within their deduced
sequences clusters of serine and threonine residues disposed
toward the carboxyl terminus or in the third cytoplasmic
loop, which may serve as substrates for BARK- and RK-like
enzymes. In the case ofthe a2-adrenergic receptors, evidence
suggests that such an enzyme mediates homologous desen-
sitization (49).
The functional analogies and structural homologies be-
tween RK and BARK are mirrored by similarities between
their cofactors arrestin and f-arrestin. These cytosolic pro-
teins, which bind to and uncouple the phosphorylated forms
of rhodopsin or f3-adrenergic receptor, respectively, from
their G protein, are 60o conserved in sequence (50). These
relationships further underscore similarities in function and
regulation of very disparate signaling systems.
Despite this evidence suggesting the generality of receptor
kinases in modulating the function of G-protein-coupled
receptors, 3ARK and RK are the only members of this
enzyme family for which structural information is presently
available. It is hoped that.the availability of their sequences
will facilitate -the identification and cloning of the other
putative members of this family, thereby expanding our
understanding of the basic mechanism by which receptor
function is regulated.
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